An Inside Job
Thyroid hormone, a small polyiodinated tyrosine-based molecule, is essential not only for the development of all vertebrates, but also for the systemic and cellular control of energy homeostasis. It is released into the plasma by the thyroid gland as either the minimally active prohormone T 4 or its biologically active counterpart T 3 . T 3 acts through its nuclear receptors [thyroid hormone receptors (TRs)], transcription factors that positively or negatively regulate expression of a wide variety of genes (1) . Its constant presence in health ensures a specific gene-expression profile, or footprint, that influences development and modulates the metabolic rate. It has been assumed by many that, under normal conditions, the thyroid signaling footprint arises directly as a result of T 3 entering target cells from the plasma. However, a large body of work has indicated that additional complexity in thyroid hormone signaling exists, because T 3 can be generated inside cells, and this T 3 can change the footprint (2) . In this issue of Endocrinology, Galton et al. (3) provide conclusive evidence, using a genetic approach, that T 3 levels in the brain depend not only on plasma T 3 , but also on local production via the type 2 deiodinase (D2).
The dogma of plasma T 3 being the only source of intracellular T 3 was initially challenged by the discovery that cells containing D2 can produce T 3 from the intracellular deiodination of T 4 . This D2-generated T 3 did not rapidly exit the cell, but rather entered the cell nucleus and only after several hours equilibrated with serum T 3 (2, 4, 5) . It is likely that the location of D2 in the endoplasmic reticulum, a compartment that is highly connected with the nuclear envelope, facilitates the access of T 3 to the nucleus (6) . As would be expected in a system of this nature, there are other enzymes that modify thyroid hormone activity. D2 is a member of a group of three deiodinases that activate or inactivate thyroid hormone by removal of outer or inner ring iodine moieties, respectively (7, 8) . Both D1 and D2 convert T 4 , the major circulating form, to T 3 . In contrast, D3 terminates the actions of both T 3 and T 4 , converting them to inactive metabolites (Fig. 1) .
Not surprisingly, the actions of D2 and D3 are integrated and thus promote T 3 homeostasis. Fluctuations in serum T 4 and T 3 concentrations lead to homeostatic, reciprocal changes in the activity of D2 and D3 (7) . As serum T 3 concentration increases, expression of the D3 gene (Dio3) is upregulated, increasing T 3 clearance, whereas expression of the D2 gene (Dio2) and its activity are down-regulated, decreasing T 3 production. Conversely, if serum T 3 concentration was to fall, down-regulation of the D3 pathway would decrease the clearance of T 3 , and an up-regulation of the D2 pathway would compensate T 3 production.
Two different but not mutually exclusive physiological roles of D2 and D3 thus emerged; the first, that these enzymes serve a homeostatic role to counteract changes in thyroid hormone supply to preserve thyroid hormone-dependent gene expression. The second is that primary changes in deiodinase activity can modulate TR saturation by increasing or decreasing cellular T 3 concentrations, and thus, generating a specific and different downstream transcriptional response from cells not expressing deiodinases. This scenario of tissueand time-specific modulation of T 3 levels would be evolutionary advantageous in vertebrates that contain a wide variety of tissue types with varying developmental and metabolic demands (9, 10) . A growing body of evidence supports the concept that D2 and D3 are tightly regulated in development and metamorphosis (11) (12) (13) . Most recently, hedgehog signaling was demonstrated to regulate D2 inactivation via ubiquination in the chicken tibial growth plate, playing a direct role in PTHrP secretion and hence skeletogenesis (14) .
In their study, Galton et al. (3) examine the role of D2 as a determinant of T 3 concentration in neonatal and adult mouse brain. Neonate mice with targeted disruption of Dio2 (D2KO) have half as much cerebral T 3 as wild-type mice, elegantly confirming the prediction derived from older kinetic studies that D2 produces a large percentage of the T 3 present in the brain (2) . The strength of the study is its genetic approach; as in the other animal models of genetically modified deiodinase expression (15) , isolated Dio2 inactivation addresses many of the technical limitations and assumptions of studies using radioactive tracers. The residual levels of T 3 present in the D2KO mouse brain can only be derived from plasma (and cerebral spinal fluid), and no mechanism exists to restore T 3 concentration in the absence of D2. These findings unequivocally demonstrate that the T 3 present in D2-expressing tissues arises from a combination of both D2-generated T 3 and plasma-derived T 3 .
Personalized Thyroid Hormone Signaling
A recent evolutionary step in our understanding of the physiological role of the deiodinases came with the recognition that primary, or initial, changes in deiodinase activity can trigger thyroid hormone-dependent metabolic or developmental events in multiple systems. The initial evidence that primary changes in deiodinase activity could elicit downstream metabolic events came from studies of brown adipose tissue (16) . D2 activation in this tissue by sympathetic signaling leads to cell-specific TR saturation with T 3 that is generated within the adipocyte, amplifying the thyroid hormone signaling for as long as the brown adipose is stimulated (17) . This mechanism is so efficient that the TRs will be saturated even if serum T 4 concentrations are reduced by more than 50% (18) . This in turn leads to the induction of T 3 -responsive thermogenic genes such as uncoupling protein 1 (19) , with neither an antecedent nor a concurrent change in plasma T 3 levels. This model was further validated using the same D2KO mouse used by Galton et al. in the present study, which has normal plasma T 3 levels but must activate shivering thermogenesis to survive in the cold (20, 21) . Thus, D2-mediated tissue-specific thyrotoxicosis can be a potent mechanism for promoting metabolic changes.
The metabolic role of D2 is not limited to adipocyte tissue. A specific role for D2 in the brain was recently discovered in the hypothalamic arcuate nucleus (ARC), which is critical for the regulation of appetite (22) . In that study, fasting mice increase D2 activity in astrocytes surrounding the arcuate nucleus, causing increased T 3 production, and hence increasing thyroid hormone signaling in these cells. This caused a subsequent increase in the amount of uncoupling protein uncoupling protein 2, and higher excitability of the neuropeptide Y/agouti-related protein neurons that regulate food intake. These molecular mechanisms resulted in a clear behavioral phenotype, with the increased D2 activity causing higher levels of rebound feeding after forced fasting. These findings follow the observation that, in the medial basal hypothalamus of the Japanese quail, D2 expression is induced by light and results in increase gonadal growth, whereas a D2 inhibitor prevents it (23) .
Despite the 50% decrease in brain T 3 levels, the authors found that the central nervous system phenotype of the D2KO mice appears to be mild compared with hypothyroid animals with respect to gene expression and behavior. This may seem surprising because there is high expression of D2 in the neonate brain, and central hypothyroidism causes severe neurological developmental problems.
The authors examined locomotion and agility, learning and memory, reflexes, and anxiety and exploratory levels in both wild-type and D2KO mice with a varied set of behavioral tests. Although the behavioral phenotype of the mice was not as severe as that seen with hypothyroid mice, there were clear defects in certain agility tasks. These findings may indicate that the residual brain T 3 , originating from plasma, was sufficient to preserve functions examined in the study. Furthermore, compensation via unknown mechanisms could be operant, as pointed out by the authors. At the neonatal time where the animals were studied, no clear compensation from the other deiodinases could be identified. However, as the authors also note, only a single neonatal age was examined, and it is possible that levels of D1 and D3 might fluctuate at earlier ages and thus limiting the differences in gene expression in the D2KO mouse brain. It is also likely that D2 gene expression might be crucial for subsets of brain cells, and that differences in gene expression would be difficult to observe without profiling specific subsets of neurons or a larger set of genes. Finally, studies of the D2KO animals under iodine deficiency or other situations where T 4 is limited may reveal a more dramatic phenotype.
The fact that the D2KO animals have substantially less T 3 in their brain tissue provides clear support for the current paradigm that thyroid hormone signaling is not equal among cells, varying based on the expression of the deiodinases (Fig.  1) . Whereas we understand some of the signals that modulate deiodinase expression and thus cell-specific thyroid hormone signaling, e.g. adrenergic signaling, bile acids/G-coupled protein receptor TGR5 pathway, Hedgehog pathway, and other morphogens (14, 24 -26) , we are left with the fascinating job of identifying the diverse signals that regulate these enzymes during development and adulthood. , and the nuclear T 3 pool. In D2-expressing cells, the nuclear pool of T 3 available to TRs originates from both plasma T 3 and T 3 generated by the D2 pathway. Antagonistically, D3 catalyzes the conversion of plasma and cellular T 4 and T 3 to the inactive metabolites reverse T 3 (rT3) and T2, respectively. D2 can be inactivated by ubiquitination (Ub) via WSB-1 (whose gene expression is increased by the Hedgehog pathway), but can be rescued by VDU1/VDU2 (whose gene expression is stimulated by cAMP). Dio2 and Dio3 gene expression are also dynamic: Dio2 expression is highly stimulated by cAMP, produced either via the ␤-adrenergic pathway or by bile acid-media stimulation of Gcoupled protein receptor TGR5, and Dio3 expression is stimulated by TGF-␤ and other growth factors. WSB1, WD repeat and SOCS box-containing protein 1; VDU1 and VDU2, VHL-interacting deubiquitinating enzyme 1 and 2.
